Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Full cumulative benefit: 3-6 months of consistent daily use
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
Cagrilintide alone: 8.1%
For patients who can pursue both, combining them in a structured protocol produces results that neither achieves alone because structural repair runs better when cellular energy is restored
Every time you puncture the rubber stopper, use a fresh sterile needle
US$ 21.34
US$ 26.83
US$ 20.74
